ALX Oncology Holdings Inc. (Nasdaq: ALXO) announced the publication of clinical data from its ASPEN-06 randomized Phase 2 trial in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE